Ourobionics

Ourobionics, founded in 2021 and headquartered in The Netherlands, is pioneering advanced biotechnology solutions. By integrating electric, magnetic, and microfluidic 3D biofabrication technologies with novel cyborganic advances, this startup is not only redefining the scope of bioprinting but also pushing boundaries towards next-generation applications.

With its compelling slogan, "We take you Beyond Bioprinting," Ourobionics aims to create high-throughput tissues and organs that incorporate embedded bioelectronics, biosensors, and therapeutic agents. This positions the company to significantly impact the fields of regenerative medicine, medical devices, and human-machine interfaces.

Their initial spinout investment, occurring on 01 January 2021, was backed by University College London. This endorsement highlights the innovative promise perceived by the academic and investment communities. As Ourobionics continues to evolve within the Biotechnology industry, it represents a promising opportunity for venture capitalists seeking disruptors in the biotech sector.